HIP
WST icon

HUB Investment Partners’s West Pharmaceutical WST Stock Holding History

HUB Investment Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$289K Buy
1,152
+334
+41% +$83.1K 0.01% 835
2025
Q4 		$225K Buy
818
+45
+6% +$12.3K 0.01% 800
2025
Q3 		$203K Buy
+773
New +$188K 0.01% 695
2024
Q4 		– Sell
-2,225
Closed -$668K – 655
2024
Q3 		$668K Hold
2,225
– – 0.03% 255
2024
Q2 		$733K Hold
2,225
– – 0.03% 227
2024
Q1 		$880K Hold
2,225
– – 0.05% 190
2023
Q4 		$783K Buy
+2,225
New +$787K 0.05% 181

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HUB Investment Partners's WST Position: Q1 2026 in Review

HUB Investment Partners increased its West Pharmaceutical (WST) stake by 41% in Q1 2026, buying an estimated $83.1K and bringing the position to 1,152 shares worth $289K. The position accounts for 0.01% of the portfolio, ranked #835.

HUB Investment Partners first reported a position in WST in Q4 2023 and has held it in 7 quarters since. The position peaked at $880K in Q1 2024. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • HUB Investment Partners held 1,152 shares of West Pharmaceutical worth $289K as of Q1 2026.
  • HUB Investment Partners bought 334 West Pharmaceutical shares in Q1 2026, an estimated $83.1K.
  • West Pharmaceutical made up 0.01% of HUB Investment Partners's portfolio in Q1 2026, its #835 holding.
  • HUB Investment Partners first reported a position in West Pharmaceutical in Q4 2023 and has held it in 7 quarters since.
  • HUB Investment Partners's West Pharmaceutical position peaked at $880K in Q1 2024.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on HUB Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.